NCT06667297

Brief Summary

Currently, altered intestinal blood flow in critically ill patients has been a hot research topic in recent years. In 2022, studies on acute mesenteric ischemia were published in top journals in critical care medicine \[Crit Care, 2022. 26(1): p.92. and Intensive Care Med, 2022. 26(2): p.92.\]. However, because the gastrointestinal tract is in the abdominal cavity and doctors lack methods to directly monitor the visceral perfusion. Therefore, there is little research on the relationship between gastrointestinal perfusion and acute gastrointestinal injury in critical ill patients. Currently, the diagnosis of acute gastrointestinal injury is mostly performed using subjective indicators and adverse outcomes that have already occurred, which results in the treatment of acute gastrointestinal injury often lagging behind. The use of color Doppler ultrasonography to assess blood flow in intestinal vessels in healthy and outpatient patients has been in use since the 1980s. Our team showed that the resistance index of the superior mesenteric artery(SMA) in postoperative cardiac surgery patients correlated with lactate values and lactate clearance \[Front Med (Lausanne), 2021.8: p.762376.\], suggesting that gastrointestinal perfusion as reflected by SMA blood flow is important for systemic resuscitation, and that Doppler indices of SMA have the potential value of reflecting intestinal hypo-perfusion. Intestinal venous blood enters the portal vein and then the liver before returning to the right heart via the inferior vena cava. Right ventricular dysfunction or abdominal hypertension could cause obstruction of portal venous return, which might lead to edema and dysfunction of the intestine. Therefore, monitoring the venous return status is crucial for intestinal perfusion. In 2012, the Venous Excess Ultrasound Score(VExUS) for evaluating venous return has been reported and it has been shown to correlate with acute kidney injury (AKI) \[Intensive Care Med, 2012. 38(3): p.384-94\]. However, there is currently no research on the correlation between acute gastrointestinal injury and venous return, and this study is innovative and exploratory.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

January 17, 2024

Completed
10 months until next milestone

First Posted

Study publicly available on registry

October 31, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2025

Completed
Last Updated

September 5, 2025

Status Verified

October 1, 2024

Enrollment Period

1.6 years

First QC Date

January 17, 2024

Last Update Submit

August 28, 2025

Conditions

Keywords

Acute gastrointestinal injuryVenous Excess Ultrasound Score

Outcome Measures

Primary Outcomes (1)

  • The Venous Excess Ultrasound Score

    The study primary endpoint was the VExUS score. It was calculated four times during the ICU stay: within 24 h of ICU admission, after day 1 (between 24 and 48 h), after day 2 (between 48 and 72 h), and at ICU discharge. The patients were classified as being congestive (VExUS≥2) or not being congestive (VExUS \< 2). A VExUS grade 2 was defined as moderate congestion, and a VExUS grade 3 was defined as severe congestion.

    Day 1(ICU admission),Day 2(between 24 and 48 h),Day 3(between 48 and 72 h),Departure Day(ICU discharge)

Secondary Outcomes (3)

  • Serologic indices of intestinal mucosal epithelial injury Plasma citrulline, plasma intestinal fatty acid binding protein, and D-lactic acid

    Day 1(ICU admission),Day 2(between 24 and 48 h),Day 3(between 48 and 72 h),Departure Day(ICU discharge)

  • Acute gastrointestinal injury

    Day 1(ICU admission),Day 2(between 24 and 48 h),Day 3(between 48 and 72 h),Departure Day(ICU discharge)

  • GIDS

    Day 1(ICU admission),Day 2(between 24 and 48 h),Day 3(between 48 and 72 h),Departure Day(ICU discharge)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult ICU admitted patients in comprehensive hospital

You may qualify if:

  • Patients with sepsis with an expected ICU stay of more than 3 days.
  • ≥18 years of age and \<80 years of age.

You may not qualify if:

  • Severe mesenteric or abdominal artery stenosis;
  • Fixed body (such as recent spinal surgery or intracranial hypertension);
  • Patients with contraindications for IAP measurement (such as patients who have recently undergone bladder surgery, been injured, or become pregnant)
  • Having undergone abdominal surgery or chest lowering involving the intestines patients undergoing aortic surgery;
  • Poor quality of abdominal ultrasound images;
  • Hydrothorax or ascites.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Critical Care Medicine of pekin union medical college hospital

Beijing, Beijing Municipality, 100730, China

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2024

First Posted

October 31, 2024

Study Start

May 1, 2023

Primary Completion

November 30, 2024

Study Completion

July 30, 2025

Last Updated

September 5, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations